Researchers in the United States have shown, for the first time, that it is possible to screen cancer patients for a broad range of cancer-causing genetic mutations as part of normal clinical practice. By identifying patients' individual genotypes within a relatively short time frame, doctors are able to target tumours with the most appropriate therapy. The study, which is published in the cancer journal, Annals of Oncology [1], was carried out in patients with non-small-cell lung cancer, but already the researchers are using it in a range of other cancers as well...
More...
More...